![](https://investorshub.advfn.com/uicon/430424.png?cb=1554906782)
Tuesday, January 16, 2024 2:50:34 PM
The MHRA typically sends a copy of the validation report confirming validation to the sponsor when they initially validate an MAA. This report is crucial for the sponsor to understand the status of their application and any necessary actions to proceed.
Here's a breakdown of what happens during validation and the information included in the report:
Validation Process:
Review: The MHRA thoroughly examines the MAA to ensure it meets all regulatory requirements, including:
Completeness
Formatting
Compliance with guidelines
Presence of necessary data and supporting documents
Identifying Issues: If any deficiencies or omissions are found, the MHRA will raise them in the validation report.
Communication: The MHRA sends the validation report to the sponsor, usually within 30 days of receiving the application.
Validation Report Contents:
Validation status: Clearly states whether the MAA has been validated or not.
List of deficiencies (if any): Details any missing information or areas that need correction.
Instructions for addressing issues: Provides guidance on how to rectify any deficiencies.
Timelines for resubmission: Specifies deadlines for resubmitting the corrected application.
Contact information for further inquiries: Provides contact details for any questions or clarifications.
Key Points:
Validation is essential: It's not an assessment of the medicine's quality, safety, or efficacy; it's a check for completeness and compliance with regulatory requirements.
Sponsor's responsibility: The sponsor must address any deficiencies highlighted in the validation report and resubmit the application accordingly.
Communication is key: The MHRA and sponsor should maintain open communication throughout the process to ensure timely validation and progression of the MAA.
Additional Information:
MHRA guidance: The MHRA publishes detailed guidance on the validation process and requirements for MAAs.
Contact the MHRA: For specific inquiries or concerns, it's always best to contact the MHRA directly.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM